Previous Article | Next Article 
Journal of Virology, December 1998, p. 10011-10019, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The LEF-4 Subunit of Baculovirus RNA Polymerase
Has RNA 5'-Triphosphatase and ATPase Activities
Jianping
Jin,1,3
Wen
Dong,2,3 and
Linda
A.
Guarino1,2,3,*
Departments of Biochemistry and
Biophysics1 and
Entomology2 and
Center for
Advanced Invertebrate Molecular Sciences,3
Texas A&M University, College Station, Texas 77843-2128
Received 8 June 1998/Accepted 9 September 1998
 |
ABSTRACT |
The baculovirus Autographa californica nuclear
polyhedrosis virus encodes a DNA-dependent RNA polymerase that is
required for transcription of viral late genes. This polymerase is
composed of four equimolar subunits, LEF-8, LEF-4,
LEF-9, and p47. The LEF-4 subunit has guanylyltransferase activity,
suggesting that baculoviruses may encode a full
complement of capping enzymes. Here we show that LEF-4 is a
bifunctional enzyme that hydrolyzes the gamma phosphates
of triphosphate-terminated RNA and also hydrolyzes ATP and GTP to the
respective diphosphate forms. Alanine substitution of five residues
previously shown to be essential for vaccinia virus RNA
triphosphatase activity inactivated the triphosphatase component of
LEF-4 but not the guanylyltransferase domain. Conversely, mutation of the invariant lysine in the guanylyltransferase domain abolished the guanylyltransferase activity without affecting
triphosphatase function. We also investigated the effects of
substituting phenylalanine for leucine at position 105, a mutation that
results in a virus that is temperature sensitive for late gene
expression. We found that this mutation had no significant effect on
the ATPase or guanylyltransferase activity of LEF-4 but resulted in a
modest decrease in RNA triphosphatase activity.
 |
INTRODUCTION |
Expression of baculovirus genes in
infected cells is temporally regulated at the transcriptional level.
Immediately after infection, only a subset of viral genes is expressed.
These immediate-early genes are transcribed by host RNA polymerase II
(pol II) and do not require the action of viral transcription factors
(6, 11, 16, 31). Expression of IE1 during this stage allows
for the transcription of the delayed-early class of genes which are
also transcribed by pol II (10, 19, 43). IE1 binds to viral
enhancer elements and presumably helps to recruit host pol II to the
early promoters (9). Many delayed-early genes encode
proteins required for viral DNA replication and late gene expression,
and expression of these proteins sets the stage for late gene
expression. The late and very late genes are transcribed by an RNA
polymerase that is resistant to
-amanitin and is chromatographically
distinct from the three host RNA polymerases (6, 42).
Recently we purified the virus-specific RNA polymerase and showed that
it was composed of four subunits, all of which are virus encoded
(13). This finding raises interesting questions regarding
the mechanisms of posttranslational processing of late viral mRNAs.
Both late and very late transcripts are capped at the 5' ends with a
typical 7-methylguanosine (m7G) structure (32). It has been
shown in other systems that these mRNA caps are added cotranscriptionally when nascent RNAs are less than 30 nucleotides in
length (1). Only mRNAs are capped, and this restriction is mediated by specific interactions of capping enzymes with their cognate RNA polymerases (4, 24). This model suggests that either the baculovirus RNA polymerase must interact with host capping
enzymes or the baculoviruses must encode their own capping enzymes.
The accompanying report (12) provides a partial answer to
this question with its demonstration that the LEF-4 subunit of Autographa californica nuclear polyhedrosis virus (AcNPV)
RNA polymerase has guanylyltransferase activity. Furthermore, analysis of the LEF-4 amino acid sequence revealed the presence of a conserved KxDG motif and homology to five additional motifs that are common to
viral and cellular guanylyltransferases, which strongly supports our
enzymatic data. Guanylyltransferase is one of the three enzymatic functions required for the formation of a m7G cap on the 5' ends of
mRNAs. The other two enzymes needed are RNA triphosphatase, which
removes the gamma phosphate from 5' triphosphate termini, and RNA
methyltransferase, which adds a methyl group to the N-7 position of the
guanosine cap. Vaccinia virus encodes a multifunctional capping enzyme
that catalyzes all three steps (15, 22, 23), which suggested
to us that LEF-4 may also have additional functions. In support of this
hypothesis, we noticed sequence similarities between the baculovirus
LEF-4 proteins and residues previously shown to be essential for
triphosphatase function of the vaccinia virus capping enzyme. Here we
report that LEF-4 has RNA triphosphatase activity. Furthermore, we show
that mutation of these conserved residues abrogates the triphosphatase
function of LEF-4.
 |
MATERIALS AND METHODS |
Purification of RNA polymerase and in vitro transcription
assays.
RNA polymerase was purified from Spodoptera
frugiperda cells infected with vBAC-RNApol as previously
described (13). In vitro transcription assays were performed
as described by Xu et al. (41).
Construction of LEF4-intein clones.
The AcNPV genomic clone
pHindIII-C was amplified by using Pfu I DNA polymerase. The
5' primer (CTGCAGCCATGGACTACGGCGATTTTGTG) inserted an NcoI site (underlined) at the ATG codon of
LEF-4. The 3' primer (TTACCCGGGCACGATTCGGTCGCG)
was designed to substitute a glycine residue for the C-terminal
aspartate and added a SmaI site (underlined) at the
C-terminal glycine. The PCR products were cloned into pBluescript and
screened by restriction enzyme digestion. A clone containing LEF-4 was
digested with NcoI and SmaI and ligated to pCYB4
(New England Biolabs) previously digested with NcoI and
SmaI. This plasmid directs the synthesis of a fusion protein
containing a self-cleavable affinity tag under control of the
tac promoter. Recombinant DNAs were screened by restriction enzyme digestion, and a clone with the correct size insert was sequenced. Alanine substitution mutations in LEF-4 were constructed by
using a QuikChange site-directed mutagenesis kit (Stratagene) as
recommended by the manufacturer. Potential mutant clones were verified
by DNA sequence analysis.
Purification of LEF-4 from bacteria.
Escherichia coli
XL1-Blue cells containing pLEF4-intein were grown to late log phase,
and expression of LEF-4 was induced by the addition of 0.4 mM
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside. After induction, cells were incubated at 20°C overnight. Cells were
harvested by centrifugation, resuspended in buffer B (50 mM Tris [pH
7.9], 0.1 mM EDTA, 500 mM NaCl, 0.1% Triton X-100), lysed by
sonication, and clarified by low-speed centrifugation. The resulting
supernatant was loaded onto a 2-ml chitin column. The column was washed
with 20 volumes buffer B plus 30 mM dithiothreitol (DTT) and allowed to
sit overnight in the presence of 30 mM DTT. Cleaved LEF-4 was eluted
with 3 column volumes of buffer B plus 30 mM DTT. Sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) followed by
staining with Coomassie brilliant blue showed a single protein that
migrated in the expected position for LEF-4. LEF-4 was further purified
by anion-exchange chromatography. Peak fractions were dialyzed against
buffer A (50 mM Tris [pH 7.9], 0.1 mM EDTA, 1 mM DTT) containing
50 mM NaCl, and the protein was applied to a Mono Q HR 5/5 column
(Pharmacia) previously equilibrated in the same buffer. The column was
washed with 10 ml of loading buffer and then eluted with a 20-ml linear
NaCl gradient from 50 to 500 mM. LEF-4 eluted from Mono Q in a single
sharp peak at 230 mM NaCl. LEF-4 was quantitated by a Coomassie blue
G250 binding assay performed as recommended by the manufacturer (Pierce).
Assay of LEF-4-GMP complex formation.
Standard reaction
mixtures (25 µl) contained 50 mM Tris-HCl (pH 7.9), 1 to 5 mM
MnCl2, 5 mM DTT, 5 µM [
-32P]GTP, and
purified RNA polymerase or LEF-4 as indicated. Samples were incubated
for 15 min at 30°C and then stopped by the addition of 1% SDS.
Samples were boiled and electrophoresed through an SDS-8%
polyacrylamide gel. Gels were fixed, dried, and exposed to film.
RNA triphosphatase assays.
RNA 5'-triphosphatase activity
was assayed by the liberation of [32P]Pi
from [
-32P]GTP-terminated RNA. Template RNA was
synthesized by in vitro transcription of pBluescript KS DNA previously
digested with BssHII. The linearized template was
transcribed with T3 RNA polymerase, using standard conditions for in
vitro transcription in the presence of [
-32P]GTP
added at a final specific activity of 5,000 cpm/pmol. This produced a
150-nucleotide-long RNA transcript specifically labeled at the 5' end.
-32P-labeled RNA was purified from transcription
reactions by three rounds of precipitation with 2.5 M LiCl, followed by
standard ethanol precipitation. Standard RNA triphosphatase assay
mixtures (20 µl) contained 50 mM Tris-HCl (pH 7.9), 5 mM DTT, 0.3 mM
MnCl2, 50 mM KCl, 1 to 5 µM RNA, and enzyme as indicated.
Reactions were incubated for 15 min at 30°C and then terminated by
the addition of 1 M formic acid. Samples were applied to
polyethylenimine (PEI)-cellulose thin-layer chromatography (TLC) plate
(J. T. Baker) and chromatographed with 0.5 M
KH2PO4 (pH 3.4). Reactions were quantitated by
scanning the TLC plate in a FUJIX BAS PhosphorImager.
ATPase assays.
Standard reaction mixtures (20 µl)
contained 50 mM Tris-HCl (pH 7.9), 5 mM DTT, 50 mM KCl, 0.3 mM
MnCl2, 1 µM [
-32P]ATP or GTP, and
enzyme as indicated. Reactions were incubated 15 min at 30°C, and
aliquots were spotted on PEI-cellulose plates. Reactions were
quantitated by scanning the plates with a PhosphorImager.
 |
RESULTS |
RNA triphosphatase activity of RNA polymerase and purified
LEF-4.
We have previously shown that the LEF-4 subunit of AcNPV
RNA polymerase has guanylyltransferase activity, suggesting that LEF-4
is an RNA capping enzyme (12). Furthermore, analysis of the
LEF-4 amino acid sequence revealed homology to six motifs that are
shared among viral and cellular guanylyltransferases in the C-terminal
half of the protein. Sequence analysis of the N-terminal portion of
LEF-4 revealed homologies with the triphosphatase domains of capping
enzymes in the poxviruses and African swine fever virus (Fig.
1). Two pairs of glutamic acid residues
and a single arginine have been shown to be essential for the RNA triphosphatase and ATPase activities of vaccinia virus capping enzyme (45). These glutamates and arginines are present in
AcNPV LEF-4 with a similar order and spacing as found in the vaccinia virus and African swine fever virus capping enzymes. Furthermore, these
residues are conserved among all three of the baculovirus LEF-4
proteins that have been submitted to protein and nucleic acid
databases. These similarities suggested to us that the LEF-4 subunit of
baculovirus RNA polymerase may have RNA triphosphatase and ATPase
activities in addition to guanylyltransferase function.

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 1.
Sequence of the LEF-4 RNA triphosphatase domain. The
amino acid sequence of the AcNPV LEF-4 from residues 1 to 194 is
aligned with the LEF-4 sequences of Bombyx mori nuclear
polyhedrosis virus (BmNPV) and Orgyia pseudotsugata nuclear
polyhedrosis virus (OpNPV) and the N-terminal regions of the capping
enzymes of vaccinia virus (VAC) and African swine fever virus (ASF).
Gaps in the sequence alignment are denoted by hyphens; residues that
are identical in at least four of the five sequences are shown in bold;
residues shown to be essential for RNA triphosphatase activity in
vaccinia virus are indicated by asterisks above the sequence
(44). Leucine 105 (underlined) is substituted with a
phenylalanine in the LEF-4 ts virus.
|
|
To test this hypothesis, purified AcNPV RNA polymerase was filtered
through Superose 6 (Fig. 2A). As
previously shown (12), a peak of guanylyltransferase
activity coincided with the peak of absorbance at 280 nm and the peak
of polymerase activity (Fig. 2B). To test for RNA triphosphatase
activity,
-32P-labeled RNA was prepared by in vitro
transcription with T3 RNA polymerase in the presence of
[
-32P]GTP. This produces an RNA transcript that is
singly labeled in the gamma phosphate position at the 5' end of the
RNA. RNA polymerase fractions were then incubated with 1 µM
[
-32P]RNA in the presence of 1 mM
MnCl2. After incubation for 15 min at 30°C, free
phosphate was separated from the RNA substrate by TLC on PEI-cellulose.
As shown in Fig. 2B, RNA polymerase fractions catalyzed the hydrolysis
of gamma phosphates from the RNA substrate. Furthermore, the extent of
cleavage was proportional to input protein, and the peak of RNA
triphosphatase activity exactly matched the peak of transcription
activity. This finding indicates that RNA triphosphatase is an integral
component of the baculovirus RNA polymerase.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
RNA triphosphatase and ATPase activities of
baculovirus RNA polymerase. (A) Gel filtration chromatography of RNA
polymerase. RNA polymerase was filtered through Superose 6 as
previously described (13). OD280, optical
density at 280 nm. (B) In vitro transcription. Fractions corresponding
to the peak of absorbance at 280 nm were assayed for in vitro
transcription. The positions of molecular size markers are shown in
kilodaltons on the left. The radiolabeled products corresponding to
initiation from the polyhedrin (polh/CFS) and 39k (39k/CFS) promoters
are shown on the right. (C) Guanyltransferase, RNA triphosphatase
(RTPase), and ATPase assays. Guanylyltransferase mixtures (25 µl)
contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 µM
[ -32P]GTP, 1 mM MnCl2, and 2 µl of
each fraction. Reactions were incubated at 30°C for 15 min, stopped
by the addition of 1% SDS, and separated on an 8% polyacrylamide gel.
RNA triphosphatase mixtures (10 µl) contained 50 mM Tris HCl (pH
7.9), 5 mM DTT, 1 mM MnCl2, 1 µM (5' termini)
-32P-labeled RNA, and 0.2 µl of each fraction.
Reactions were incubated at 30°C for 15 min, stopped by the addition
of 1 M formic acid, spotted on PEI-cellulose plates, and quantitated by
scanning in a PhosphorImager. Picomoles of phosphate released is
plotted on the right. ATPase mixtures (10 µl) contained 50 mM
Tris HCl (pH 7.9), 5 mM DTT, 1 mM MnCl2, 1 µM
[ -32P]ATP, and 0.2 µl of each fraction. ,
EpG; and , Pi released.
|
|
To examine the specificity of the triphosphatase activity, fractions
were also incubated with [
-32P]ATP, and the
release of free phosphate was monitored by PEI chromatography. The peak
of activity of gamma phosphate release exactly coincided with the three
other enzymatic functions analyzed (Fig. 2B). Essentially identical
results were obtained with [
-32P]GTP as the
substrate (data not shown). This finding suggests that the baculovirus
enzyme, like the vaccinia virus capping enzyme, has nucleoside
triphosphatase activity in addition to RNA triphosphatase activity.
Triphosphatase activity of purified LEF-4.
To demonstrate that
the RNA triphosphatase and ATPase activities were due to LEF-4 and
not to other components of the RNA polymerase, purified LEF-4 was also
assayed for both activities (Fig. 3).
LEF-4 was overexpressed in baculovirus-infected cells and purified to
near homogeneity by heparin-agarose and Mono Q chromatography as
previously described (12). Purified LEF-4 was then filtered
through a Superdex 200 gel exclusion column. Fractions corresponding to
the peak of UV absorbance were assayed for guanylyltransferase
activity, using the GMP label transfer assay. The same fractions were
also active in the RNA triphosphatase and ATPase assays. The
specific activities of the three enzymatic functions were nearly
constant across the peak of protein. This result is consistent with our
hypothesis that the triphosphatase and ATPase activities of RNA
polymerase map to the LEF-4 subunit.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
RNA triphosphatase and ATPase activities of LEF-4.
LEF-4 was purified by recombinant baculovirus-infected cells and
filtered through Superdex 200 as previously described (12).
Fractions corresponding to the peak of absorbance at 280 nm were
assayed for guanylyltransferase, RNA triphosphatase (RTPase), and
ATPase activities as described in the legend to Fig. 2.
Guanylyltransferase activity is plotted on the left; picomoles of
phosphate released from gamma-labeled RNA or ATP is plotted on the
right. , EpG; and , Pi released.
|
|
Characterization of the RNA triphosphatase component of LEF-4.
The RNA triphosphatase activity of LEF-4 was absolutely dependent on
the addition of a divalent cation (Fig.
4A). Manganese was a more efficient
cofactor than was magnesium at all concentrations tested. Activity
peaked sharply at 0.3 mM and declined at higher concentrations.
Magnesium was active over a broader range and was maximal at 1 mM, at
which concentration the activity was 30% of that achieved with
manganese. Essentially the same results were seen with RNA polymerase
(data not shown).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 4.
Characterization of the RNA triphosphatase activity of
LEF-4. (A) Cation requirements. Reaction mixtures contained 50 mM Tris
HCl (pH 7.9), 5 mM DTT, 1 µM (5' termini) -32P-labeled
RNA, 0.1 pmol of LEF-4, and divalent cation as indicated in 20 µl.
Reactions were incubated at 30°C for 15 min, spotted on PEI-cellulose
plates, and quantitated by scanning in a PhosphorImager. Picomoles of
phosphate released is plotted as a function of magnesium or manganese
concentration. (B) Protein titration. Reaction mixtures (20 µl)
contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 µM
-32P-labeled RNA, 0.3 mM MnCl2, and AcNPV
RNA polymerase or LEF-4 purified from baculovirus-infected insect cells
as indicated. Picomoles of phosphate released is plotted as a function
of input protein.
|
|
Under optimal conditions, the extent of gamma phosphate hydrolysis
during a 15-min incubation was proportional to input protein with both
sources of enzyme (Fig. 4B). In the linear range of enzyme
concentration, the turnover number for RNA polymerase was 0.16 fmol/s/fmol of enzyme, while that of LEF-4 was 0.31 fmol/s/fmol.
Characterization of the nucleoside triphosphatase component of
LEF-4.
Hydrolysis of ATP was also absolutely dependent on the
addition of a divalent cation (Fig. 5A).
In the presence of manganese, ATPase activity increased
linearly from 0.08 to 0.6 µM and then declined slowly at higher
concentrations. Magnesium was a poor substitute for manganese, unlike
the results observed for magnesium in the RNA triphosphatase assays.
The ATPase activity at 10 mM magnesium was only 1% of the maximal
activity gained with manganese.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 5.
Characterization of the nucleoside triphosphatase
activity of LEF-4. (A) Cation requirements. Reaction mixtures contained
50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 µM
[ -32P]ATP, 0.2 pmol of LEF-4 purified from
baculovirus-infected cells, and divalent cation as indicated in 20 µl. Reactions were incubated at 30°C for 15 min, spotted on
PEI-cellulose plates, and quantitated by scanning in a PhosphorImager.
Picomoles of phosphate released is plotted as a function of magnesium
or manganese concentration. (B) Phosphate specificity. Reaction
mixtures contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 µM
[ -32P]GTP, 0.3 mM MnCl2 and 0.2 pmol
of LEF-4 purified from baculovirus-infected cells in 20 µl. Picomoles
of GDP or GMP produced is plotted as a function of input protein.
|
|
Specificity for the gamma phosphate was monitored by using
[
-32P]GTP as the substrate (Fig. 5B). GDP
accumulated linearly at a rate of 6.4 pmol/min/pmol of enzyme. GDP
was slowly converted to GMP at a rate of 0.22 pmol/min/pmol of
enzyme. Free phosphate was not detected during the 30-min time course.
Structure-function analysis of LEF-4.
To confirm that the
RNA triphosphatase and ATPase activities observed were
attributable to LEF-4, we expressed three mutated versions of
LEF-4. Four glutamates and one arginine corresponding to residues
previously shown to be essential for vaccinia virus triphosphatase
activity (45) were changed to alanine. We also expressed a
mutant protein in which the lysine residue of the guanylyltransferase
KxDG motif was substituted with alanine. For ease of expression and
purification, the mutant LEF-4 proteins were expressed in the
E. coli expression system IMPACT I (New England
Biolabs). This system produces fusion proteins with a self-cleavable
intein tag linked to a chitin-binding domain. Cleavage of the intein
tag produces a protein that is identical to the wild-type LEF-4 except
for the substitution of a glycine residue for the C-terminal
asparagine. This substitution does not affect the enzymatic activities
of the protein, as all of our assays indicated that LEF-4 produced in
E. coli was equivalent to native LEF-4 purified from
baculovirus-infected cells (Fig. 6 and
data not shown).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 6.
Purification and guanylyltransferase activities of LEF-4
mutants. (A) SDS-PAGE analysis of wild-type (wt) and mutant (E9/11A,
R51A, K255A, and E181/183A) proteins purified from bacteria. Protein
(1.35 µg per lane) purified by Mono Q chromatography was analyzed on
SDS-8% polyacrylamide gels. The migration of prestained molecular
markers is indicated on the left. (B) Guanylyltransferase assays.
Guanylyltransferase activities were measured by formation of a covalent
enzyme-GMP complex. Reaction mixtures (25 µl) contained 50 mM Tris
(pH 7.9), 5 mM DTT, 5 mM MnCl2, 1 µM
[32P]GTP, and 0.1 µg of the indicated protein.
Reactions were stopped by the addition of 1% SDS and electrophoresed
through an SDS-8% polyacrylamide gel. The positions of
14C-labeled protein markers are shown in kilodaltons on the
left. The position of LEF-4 is indicated on the right.
|
|
After elution from the intein column, the LEF-4 protein samples were
further purified by Mono Q chromatography. Figure 6 shows that the
wild-type and mutant proteins expressed in E. coli were purified to single-band homogeneity. Guanylyltransferase assays were
performed to ensure that the mutant proteins were correctly folded. The
specific activities of the mutant and wild-type enzymes were determined
within the linear range of enzymatic activity. With the wild-type
enzyme, 0.5% of the available binding sites were radiolabeled,
comparable to the level observed with native LEF-4 produced in
baculovirus-infected cells (12). The activities of the
triphosphatase mutants were equivalent to that of the wild-type protein, with the exception of that of E9/11A, which was 2.5-fold higher than the activity of the wild-type protein. As expected, the
guanylyltransferase activity of the K255A mutant was undetectable. It
has been established in other systems that nucleotidyltransferases form
covalent intermediates with adenylate or guanylate linked to the lysine
residue of the KxDG motif (5, 25). Thus, analysis of this
mutation serves to demonstrate that the guanylyltransferase and
triphosphatase activities are localized to separate domains.
RNA triphosphatase activities of the mutant and wild-type enzymes were
assayed by release of 32Pi from 1 µM
[
-32P]RNA. The wild-type protein hydrolyzed 210 pmol of Pi per pmol of protein in a 15-min incubation. The
specific activities of the mutant proteins relative to wild type are
shown in Table 1. RNA triphosphatase
activity was undetectable in the E181/183A mutant, reduced 100-fold in
the E9/11A mutant, and reduced to 2.5% of control levels in the R51A
mutant. ATPase activities were assayed by release of
32Pi from 1 µM
[
-32P]ATP. The wild-type enzyme liberated 108 pmol
of Pi per mol of LEF-4 in 15 min at 30°C. The activity of
all three mutants was reduced to less than 1% of that of the control.
The K255A mutant retained both RNA triphosphatase and
ATPase activities. These data are consistent with results obtained
with corresponding mutations in the vaccinia virus capping enzyme
(44).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Mutational effects of alanine substitutions on
guanylyltransferase, RNA triphosphatase, and ATPase activities
of LEF-4a
|
|
Analysis of the L105F LEF-4 mutant.
The lef-4 gene
was first described as the site of a mutation in a virus that was
temperature sensitive (ts) for expression of late genes
(28). The ts lesion in LEF-4 was mapped to a
single-nucleotide transversion resulting in a substitution of
phenylalanine for leucine at amino acid residue 105 (3),
within the RNA triphosphatase domain (Fig. 1). This finding suggested
the possibility that the defect in late gene expression may be due to
incomplete hydrolysis of the gamma phosphates of late transcripts and
therefore inefficient capping of late transcripts. One function of the
m7G cap is to protect mRNAs from degradation. Therefore, a defect
in capping could lead to rapid turnover of late mRNAs, producing
the phenotype observed in this mutant.
To characterize the L105F mutation, we expressed a mutant protein
with this substitution as described above for the alanine substitutions. The protein was expressed at 20°C and tested for guanylyltransferase, RNA triphosphatase, and ATPase
activities at 25 and 33°C. As shown in Fig.
7A, the purity of the L105F protein was commensurate with that of the wild-type protein.
Guanylyltransferase activities were also equivalent to those of the
wild-type protein at both permissive and nonpermissive temperatures.
With both mutant and wild-type proteins, the activity was slightly
higher at 25 than at 30°C, while the activity was reduced by half at
the higher temperature (Fig. 7B). The wild-type protein bound GMP to an
extent that occupied 0.7% of available sites at 25°C and only 0.2%
at 33°C. The activity of the mutant protein was approximately 85% that of the wild type at both temperatures. These data indicate that
substitution of the phenylalanine for leucine did not lead to
temperature-dependent unfolding of LEF-4.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 7.
Characterization of the L105F protein. (A) SDS-PAGE
analysis of wild-type (wt) and L105F mutant LEF-4 proteins purified
from bacteria. Protein (1 µg per lane) purified by Mono Q
chromatography was analyzed on SDS-8% polyacrylamide gels. The
migration of prestained molecular markers is indicated in kilodaltons
on the left. (B) Guanylyltransferase assays. Guanylyltransferase
activities were measured by formation of a covalent enzyme-GMP complex.
Reactions mixtures (25 µl) contained 50 mM Tris (pH 7.9), 5 mM DTT, 5 mM MnCl2, 1 µM [32P]GTP, and 0.1 µg
of the indicated protein. Reactions were incubated for 15 min at 25°C
(lanes 2 and 4) or 33°C (lanes 3 and 5), stopped by the addition of
1% SDS, and electrophoresed through an SDS-8% polyacrylamide gel.
The positions of 14C-labeled protein markers are shown in
kilodaltons on the left. The migration of LEF-4 is indicated on the
right.
|
|
The RNA triphosphatase and ATPase activities of L105F
were determined by protein titration at the permissive and
nonpermissive temperatures. Both activities were indistinguishable
from that of the wild-type protein at the permissive temperature (Table 2). At the nonpermissive temperature, the
ATPase activity of the ts mutant was equivalent to
wild-type activity but the RNA triphosphatase activity was reduced to
74% of the wild-type level. Mutational analyses of the vaccinia virus
capping enzyme indicate that the RNA triphosphatase and
ATPase activities map to the same active site (25,
44), and the data presented in Table 1 suggest that both
activities of LEF-4 also colocalize. Therefore, it is possible that
this residue maps to an RNA binding site rather than to the catalytic
site. However, this effect is minimal and unlikely to account for the
ts phenotype observed for the LEF-4 mutant virus.
Thermal stability of L105F.
To further investigate the
activities of L105F at the nonpermissive temperature, thermal
inactivation profiles for the three enzymatic activities were produced
(Fig. 8). Wild-type and
L105F proteins were incubated at the permissive (25°C) or
nonpermissive (33°C) temperature for defined lengths of time and then
tested for guanylyltransferase and triphosphatase activities at the
nonpermissive temperature. In addition, we analyzed the effect of
preincubation at 37°C, which is higher than the nonpermissive
temperature in vivo.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 8.
Thermal stability of LEF-4 L105F. (A)
Guanylyltransferase assays. Guanylyltransferase activities were
measured by formation of a covalent enzyme-GMP complex. Reactions
mixtures (25 µl) contained 50 mM Tris (pH 7.9), 5 mM DTT, 5 mM
MnCl2, 5 µM [32P]GTP, and 0.01 µM
wild-type (WT) or L105F protein. After incubation in the absence of GTP
for the indicated times at 25, 33, or 37°C, the samples shifted to
25°C, GTP was added, and the samples were incubated for 15 min.
Reactions were quantitated by scanning of SDS-protein gels in a
PhosphorImager. EpG, LEF-4. (B) ATPase assays. Reaction mixtures
(20 µl) contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 µM
[ -32P]ATP, 0.3 mM MnCl2 and 0.01 µM of wild-type or L105F
protein. (C) RNA triphosphatase assays. Reaction mixtures (20 µl)
contained 50 mM Tris HCl (pH 7.9), 5 mM DTT, 1 µM
-32P-labeled RNA, 0.3 mM MnCl2, and 5 nM of
wild-type or L105F protein. Samples for RNA triphosphatase and
ATPase activities were incubated for the indicated amounts of time
at 25, 33, or 37°C in the absence of substrate; then the samples were
shifted to 25°C, RNA or ATP was added, and the samples were incubated
for 15 min. Reactions were quantitated by scanning TLC plates in a
PhosphorImager. Each point represents the average of triplicate
reactions.
|
|
The temperature inactivation profile for the guanylyltransferase
activities indicated that both wild-type and mutant enzymes were
sensitive to incubation at elevated temperatures (Fig. 8A). After 30 min at 37°C, the activity of the wild-type enzyme was reduced to 1%
of control levels (no preincubation). Incubation for 30 min at 33 or at
25°C reduced activity to approximately 20% of control levels. At 25 and 33°C, the inactivation profiles of the L105F mutant mirrored
those of the wild type, and the values averaged 87% of wild-type
values. At 37°C, the difference between the two proteins was greater.
The activity of L105F was averaged 50% of that of the wild type after
incubation at 37°C.
ATPase profiles were similar for the wild type and L105F. The
activities of both enzymes in ATPase assays decreased approximately 50% after 30 min of preincubation at 25°C, 56% at 33°C, and 74% at 37°C. RNA triphosphatase activities showed the highest level of
thermal stability for both proteins. The inactivation profiles for
L105F and the wild type were indistinguishable at 25 and 33°C, with
both enzymes losing only 10% of their activities after 30 min of
preincubation. L105F was somewhat more sensitive than the wild type to
incubation at 37°C and retained only 60% of its activity after 30 min, while the wild-type enzyme retained 78% of its activity.
 |
DISCUSSION |
Eukaryotic viruses that replicate in the cytosol have evolved
diverse strategies to ensure that their mRNAs are capped
(2). RNA viruses either steal their caps from cellular
mRNAs, encode their own capping enzymes, or circumvent the need for
a cap by including elements in their RNAs that promote cap-independent translation. Poxviruses and African swine fever virus encode their own
capping and methylating enzymes, while most other DNA viruses replicate
in the nucleus and rely on host capping enzymes. Here we present data
showing that baculoviruses have provided yet another solution to the
capping problem. They replicate in the nucleus yet still encode at
least two of the enzymes required for cap formation. Moreover, these
enzymatic functions are incorporated into the baculovirus RNA polymerase.
In the accompanying report, we present data suggesting that LEF-4 is a
guanylyltransferase (12). Analysis of the LEF-4 amino acid
sequence revealed homology to five collinear motifs that are shared
among viral and cellular guanylyltransferases (40), confirming the enzymatic data. These motifs are localized to the C-terminal half of the protein. Here we show that the N-terminal portion of the molecule shows local sequence conservation with the
triphosphatase domain of vaccinia virus capping enzyme. Five residues
in the vaccinia enzyme were previously shown to be required for
ATPase and RNA triphosphatase activities (45). These
amino acids are conserved among all of the baculovirus LEF-4 proteins in the same order and with similar spacing, suggesting that LEF-4 was
also a triphosphatase.
We demonstrated that both RNA 5'-triphosphatase and ATPase
activities copurified with the guanylyltransferase and transcription activities of AcNPV RNA polymerase. The specific activities of the four
enzymes were essentially linear across the peak of protein, strongly
suggesting that all four enzymes were contained within the same protein
complex. Moreover, we showed that the RNA triphosphatase and ATPase
activities coeluted, with the peak of LEF-4 protein when overexpressed
as a single subunit. Further confirmation was provided by mutagenesis
data showing that substitution of alanine at critical residues
abrogated the triphosphatase and ATPase activities of LEF-4.
RNA 5'-triphosphatase is required for the hydrolysis of gamma
phosphates from primary transcripts which have triphosphate termini. The resultant diphosphate-terminated RNAs serve as
acceptors for the guanylyltransferase reaction in the production of
GpppN caps on the ends of RNAs. Although we have not demonstrated that LEF-4 is capable of transferring GMP to diphosphate-terminated RNAs, it
seems reasonable to propose that the function of LEF-4 is to cap RNAs
transcribed by the baculovirus RNA polymerase.
Gross and Shuman (8) have recently demonstrated that
AcNPV encodes another protein with RNA 5'-triphosphatase
function. This protein, protein tyrosine phosphatase (PTPase), was
originally identified on the basis of sequence homology with protein
tyrosine/serine phosphatases (18, 36), and it was shown to
be active in the hydrolysis of phosphotyrosine- and
phosphoserine-containing substrates. However, the identification of a
Caenorhabditis elegans RNA 5'-triphosphatase with a protein
tyrosine/serine signature motif suggests that RNA may be the preferred
substrate for some members of this family (37). Indeed,
Gross and Shuman showed that PTPase hydrolyzed RNA substrates at a rate
several orders of magnitude higher than that reported for protein
substrates. Thus, it seems likely that this protein functions as an RNA
5'-triphosphatase and not a protein phosphatase. However,
ptpase is not essential for viral replication and is not
required for the transient expression of late and viral late genes,
while lef-4 is required for both transient expression and
productive viral infection (3, 20, 38). Furthermore, LEF-4
is part of the RNA polymerase complex and so is optimally positioned to
serve as the primary protein involved in hydrolysis of primary termini
of baculovirus late mRNAs.
The function of the ATPase activity of LEF-4 is unknown, as is the
role of the ATP hydrolysis of the vaccinia virus capping enzyme.
Vaccinia virus capping enzyme is also required for transcription termination, and early experiments suggested that the ATPase
activity of vaccinia virus capping enzyme was required for
transcription termination (14). However, recent
alanine mutagenesis experiments showed that capping enzymes which
are deficient in ATP hydrolysis are still active in promoting
transcription termination (45). As yet, nothing is known
regarding the mechanisms of transcription termination in the
baculovirus system. Development of a termination assay will be
essential in determining whether LEF-4 is involved in termination as
well as capping of viral RNAs.
The ts mutation previously mapped to the lef-4
gene results in a substitution of phenylalanine for leucine at position
105 (3). The phenotype of this mutant is consistent with a
defect in late gene expression, as it is characterized by decreased
numbers of virions and decreased levels of late gene expression. L105 is located in the triphosphatase domain; therefore, we considered the
possibility that the ts phenotype was due to a defect in
mRNA capping. The mRNA cap plays essential roles in mRNA
stability and initiation of translation. Thus, it seemed possible that
production of uncapped RNAs could result in decreased translation of
viral structural proteins due to rapid turnover of late RNAs.
Bombyx mori and Orgyia pseudotsugata nuclear
polyhedrosis viruses have leucine or valine at this position; thus,
there is some sequence conservation among the baculoviruses at L105. To
address this question, we produced a mutant LEF-4 protein with a
phenylalanine at residue 105. The enzymatic activities of wild-type
protein and L105F were compared by protein titration experiments at
permissive and nonpermissive temperatures. We found that there were
no significant differences in the guanylyltransferase or
ATPase activities of the mutant protein relative to the wild-type
protein at either the permissive or nonpermissive temperature.
There was a slight, but reproducible, decrease (74%) in the RNA
triphosphatase activity of the mutant relative to the wild-type protein
at the nonpermissive temperature. The specific effect on RNA
triphosphatase activity suggests that L105 may be part of the RNA
binding site. RNA triphosphatase and ATPase activities map to the
same active site; therefore, L105 is probably not part of the catalytic
site, as the mutation affected only one of the activities.
More extensive thermal inactivation profiles showed that the thermal
stability of L105F was equivalent to that of the wild type at
permissive and nonpermissive temperatures. However, the guanylyltransferase and RNA triphosphatase activities of L105F were
more sensitive than wild-type activities to prolonged incubation at
37°C, although the ATPase activities were equivalent at this temperature. Thus, differences were only seen at temperatures which are
not physiologically relevant.
Further experimentation will be required to determine
whether the phenotype of the L105F mutant is due to a
defect in mRNA capping. A decrease in RNA triphosphatase
activity is unlikely to result in a ts phenotype. It is well
established that in the vaccinia virus system the rate of gamma
phosphate hydrolysis greatly exceeds the rate of cap formation
(39). RNAs with triphosphate ends are efficiently capped by
the vaccinia virus capping enzyme (45), but it is unlikely
that the resulting tetraphosphate caps would be efficiently translated.
Therefore, significant differences in the activities of the two enzymes
are required to ensure that guanylyltransferase never encounters a
triphosphate end, thus preventing the formation of tetraphosphate cap
structures. We cannot directly measure the relative rates of RNA
triphosphatase and capping in LEF-4, because the enzyme is not active
in the transfer of GMP to RNA. However, it seems reasonable to assume that the baculovirus enzyme is also much more active in hydrolysis than
in guanylyltransferase. And if this is true, a 74% decrease in
triphosphatase probably would not significantly alter the formation of
triphosphate caps. Furthermore, even if 74% of the late RNAs were not
capped or were incorrectly capped, the result would probably not be a
lethal phenotype but instead merely a slight reduction in the synthesis
of late viral proteins.
Comparison of the sequences surrounding L105 with sequences of the
poxvirus capping enzymes or African swine fever virus capping enzyme
did not reveal any sequence similarity in this region. This finding is
consistent with our conclusions that L105 is not part of the active
site of the enzyme and raises the possibility that substitution of
phenylalanine, which has a large aromatic ring, destabilizes the
interactions between the RNA polymerase subunits. Development of a
reconstitution system for the baculovirus RNA polymerase should help to
answer this question.
 |
ACKNOWLEDGMENT |
This research was supported by grant MCB 95-06233 from the
National Science Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843-2128. Phone: (409) 845-7556. Fax: (409) 845-9274. E-mail: lguarino{at}tamu.edu.
 |
REFERENCES |
| 1.
|
Babich, A.,
J. R. Nevins, and J. E. Darnell.
1980.
Early capping of transcripts from the adenovirus major late transcription unit.
Nature
287:246-248[Medline].
|
| 2.
|
Bisaillon, M., and G. Lemay.
1997.
Viral and cellular enzymes involved in synthesis of mRNA cap structure.
Virology
236:1-7[Medline].
|
| 3.
|
Carstens, E. B.,
H. Chan,
H. Yu,
G. V. Williams, and R. Casselman.
1994.
Genetic analysis of temperature-sensitive mutations in baculovirus late expression factors.
Virology
204:323-337[Medline].
|
| 4.
|
Cho, E.-J.,
T. Takagi,
C. R. Moore, and S. Buratowski.
1997.
mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain.
Genes Dev.
11:3319-3326[Abstract/Free Full Text].
|
| 5.
|
Cong, P., and S. Shuman.
1993.
Covalent catalysis in nucleotidyl transfer: a KTDG motif essential for enzyme-GMP complex formation by mRNA capping enzyme is conserved at the active sites of RNA and DNA ligases.
J. Biol. Chem.
268:7256-7260[Abstract/Free Full Text].
|
| 6.
|
Fuchs, L. Y.,
M. S. Woods, and R. F. Weaver.
1983.
Viral transcription during Autographa californica nuclear polyhedrosis virus infection: a novel RNA polymerase induced in infected Spodoptera frugiperda cells.
J. Virol.
48:641-646[Abstract/Free Full Text].
|
| 7.
|
Glocker, B.,
R. R. Hoopes, and G. F. Rohrmann.
1993.
In vitro transcription from baculovirus late gene promoter: accurate mRNA initiation by nuclear extracts prepared from infected Spodoptera frugiperda cells.
J. Virol.
67:3771-3776[Abstract/Free Full Text].
|
| 8.
|
Gross, C. H., and S. Shuman.
1998.
Characterization of a baculovirus-encoded RNA 5'-triphosphatase.
J. Virol.
72:7057-7063[Abstract/Free Full Text].
|
| 8a.
|
Gross, C. H., and S. Shuman.
1998.
RNA 5'-triphosphatase, nucleoside triphosphatase, and guanylyltransferase activities of the baculovirus LEF-4 protein.
J. Virol.
72:10020-10028[Abstract/Free Full Text].
|
| 9.
|
Guarino, L. A., and W. Dong.
1991.
Transient expression of an enhancer-binding protein in insect cells transfected with the Autographa californica nuclear polyhedrosis virus IE1 gene.
J. Virol.
65:3676-3680[Abstract/Free Full Text].
|
| 10.
|
Guarino, L. A., and M. Smith.
1992.
Regulation of delayed-early gene transcription of dual TATA boxes.
J. Virol.
66:3722-3739.
|
| 11.
|
Guarino, L. A., and M. D. Summers.
1986.
Functional mapping of a trans-activating gene required for expression of a baculovirus delayed-early gene.
J. Virol.
57:563-571[Abstract/Free Full Text].
|
| 12.
|
Guarino, L. A.,
J. Jin, and W. Dong.
1998.
Guanylyltransferase activity of the LEF-4 subunit of baculovirus RNA polymerase.
J. Virol.
72:10003-10010[Abstract/Free Full Text].
|
| 13.
|
Guarino, L. A.,
B. Xu,
J. Jin, and W. Dong.
1998.
A virus-encoded RNA polymerase purified from baculovirus-infected cells.
J. Virol.
72:7985-7991[Abstract/Free Full Text].
|
| 14.
|
Hagler, J.,
Y. Luo, and S. Shuman.
1994.
Mechanism of factor-dependent transcription termination by vaccinia RNA polymerase: kinetic coupling and requirement for ATP hydrolysis.
J. Biol. Chem.
269:10050-10060[Abstract/Free Full Text].
|
| 15.
|
Higman, M. A.,
L. A. Christen, and E. G. Niles.
1994.
The mRNA (guanine-7-) methyltransferase domain of the vaccinia virus mRNA capping enzyme: expression in E. coli and structural and kinetic comparison to the intact capping enzyme.
J. Biol. Chem.
267:14974-14981[Abstract/Free Full Text].
|
| 16.
|
Hoopes, R. R., Jr., and G. F. Rohrmann.
1991.
In vitro transcription of baculovirus immediate early genes: accurate initiation by nuclear extracts from both insect and human cells.
Proc. Natl. Acad. Sci. USA
88:4513-4517[Abstract/Free Full Text].
|
| 17.
|
Huh, N. E., and R. F. Weaver.
1990.
Identifying the RNA polymerases that synthesize specific transcripts of the Autographa californica nuclear polyhedrosis virus.
J. Gen. Virol.
71:195-201[Abstract/Free Full Text].
|
| 18.
|
Kim, D., and R. F. Weaver.
1993.
Transcription mapping and functional analysis of the protein tyrosine/serine phosphatase (PTPase) gene of the Autographa californica nuclear polyhedrosis virus.
Virology
195:587-596[Medline].
|
| 19.
|
Kogan, P. H., and G. W. Blissard.
1994.
A baculovirus gp64 early promoter is activated by host transcription factor binding to CACGTG and GATA elements.
J. Virol.
68:813-822[Abstract/Free Full Text].
|
| 20.
|
Li, Y., and L. K. Miller.
1995.
Properties of a baculovirus mutant defective in the protein phosphatase gene.
J. Virol.
69:4533-4537[Abstract].
|
| 21.
|
Mans, R. M., and D. Knebel-Morsdorf.
1998.
In vitro transcription of pe38/polyhedrin hybrid promoters reveals sequences essential for recognition by the baculovirus-induced RNA polymerase and for the strength of very late viral promoters.
J. Virol.
72:2991-2998[Abstract/Free Full Text].
|
| 22.
|
Mao, X., and S. Shuman.
1994.
Intrinsic RNA (guanine-7) methyltransferase activity of the vaccinia virus capping enzyme D1 subunit is stimulated by the D12 subunit: identification of amino acid residues in the D1 protein required for subunit association and methyl group transfer.
J. Biol. Chem.
269:24472-24479[Abstract/Free Full Text].
|
| 23.
|
Martin, S. A.,
E. Paoletti, and B. Moss.
1975.
Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.
J. Biol. Chem.
250:9322-9329[Abstract/Free Full Text].
|
| 24.
|
McCracken, S.,
N. Fong,
E. Rosonina,
K. Yankulov,
G. Brothers,
D. Siderovski,
A. Hessel,
S. Foster,
Amgen EST Program,
S. Shuman, and D. L. Bentley.
1997.
5'-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II.
Genes Dev.
11:3306-3318[Abstract/Free Full Text].
|
| 25.
|
Myette, J., and E. G. Niles.
1996.
Characterization of the vaccinia virus RNA 5' triphosphatase and nucleoside phosphohydrolase activities: demonstration that both activities are carried out at the same active site.
J. Biol. Chem.
271:11936-11944[Abstract/Free Full Text].
|
| 26.
|
Miller, L. K. (ed.).
1997.
The baculoviruses.
Plenum Press, New York, N.Y.
|
| 27.
|
Niles, E. G., and L. Christen.
1993.
Identification of the vaccinia virus mRNA guanylyltransferase active site lysine.
J. Biol. Chem.
268:24968-24989.
|
| 28.
|
Partington, S.,
H. Yu,
A. Lu, and E. B. Carstens.
1990.
Isolation of temperature-sensitive mutants of Autographa californica nuclear polyhedrosis virus: phenotypic characterization of mutants defective in very late gene expression.
Virology
175:91-102[Medline].
|
| 29.
|
Passarelli, A. L., and L. K. Miller.
1993.
Identification of genes encoding late expression factors located between 56.0 and 65.4 map units of the Autographa californica nuclear polyhedrosis virus genome.
Virology
197:704-714[Medline].
|
| 30.
|
Passarelli, A. L.,
J. W. Todd, and L. K. Miller.
1994.
A baculovirus gene involved in late gene expression predicts a large polypeptide with a conserved motif of RNA polymerases.
J. Virol.
68:4673-4678[Abstract/Free Full Text].
|
| 31.
|
Pullen, S. S., and P. D. Friesen.
1995.
Early transcription of the ie1 transregulator gene of Autographa californica nuclear polyhedrosis virus is regulated by DNA sequences within its 5' noncoding leader region.
J. Virol.
69:156-165[Abstract].
|
| 32.
|
Qin, J.-C., and R. F. Weaver.
1982.
Capping of viral RNA in cultured Spodoptera frugiperda cells infected with Autographa californica nuclear polyhedrosis virus.
J. Virol.
43:234-240[Abstract/Free Full Text].
|
| 33.
|
Rankin, C. B.,
B. G. Ooi, and L. K. Miller.
1988.
Eight base pairs encompassing the transcriptional start point are the major determinant for baculovirus polyhedrin expression.
Gene
70:39-49[Medline].
|
| 34.
|
Rohrmann, G. F.
1986.
Polyhedrin structure.
J. Gen. Virol.
67:1499-1508[Abstract/Free Full Text].
|
| 35.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 36.
|
Sheng, Z., and H. Charbonneau.
1993.
The baculovirus Autographa californica encodes a protein tyrosine phosphatase.
J. Biol. Chem.
268:4728-4733[Abstract/Free Full Text].
|
| 37.
|
Takagi, T.,
C. R. Moore,
F. Diehn, and S. Buratowski.
1997.
An RNA 5' triphosphatase related to the protein tyrosine phosphatases.
Cell
89:867-873[Medline].
|
| 38.
|
Todd, J. W.,
A. L. Passarelli, and L. K. Miller.
1995.
Eighteen baculovirus genes, including lef-11, p35, 39k, and p47, support late gene expression.
J. Virol.
69:968-974[Abstract].
|
| 39.
|
Venkatesan, S.,
A. Gershowitz, and B. Moss.
1980.
Modification of the 5' end of mRNA: association of RNA triphosphatase with the RNA guanyltransferase-RNA (guanine-7-) methyltransferase complex from vaccinia virus.
J. Biol. Chem.
255:903-908[Abstract/Free Full Text].
|
| 40.
|
Wang, S. P.,
L. Deng,
C. K. Ho, and S. Shuman.
1997.
Phylogeny of mRNA capping enzymes.
Proc. Natl. Acad. Sci. USA
94:9573-9578[Abstract/Free Full Text].
|
| 41.
|
Xu, B.,
S. Yoo, and L. A. Guarino.
1995.
Differential transcription of baculovirus late and very late promoters: fractionation of nuclear extracts by phosphocellulose chromatography.
J. Virol.
69:2912-2917[Abstract].
|
| 42.
|
Yang, C. L.,
D. A. Stetler, and R. F. Weaver.
1991.
Structural comparison of the Autographa californica nuclear polyhedrosis virus-induced RNA polymerases from the host, Spodoptera frugiperda.
Virus Res.
20:251-264[Medline].
|
| 43.
|
Yoo, S., and L. A. Guarino.
1994.
The Autographa californica nuclear polyhedrosis virus ie2 gene encodes a transcriptional regulator.
Virology
202:746-753[Medline].
|
| 44.
|
Yu, L., and S. Shuman.
1996.
Mutational analysis of the triphosphatase domain of vaccinia virus mRNA capping enzyme.
J. Virol.
70:6162-6168[Abstract].
|
| 45.
|
Yu, L.,
A. Martins,
L. Deng, and S. Shuman.
1997.
Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme.
J. Virol.
71:9837-9843[Abstract].
|
Journal of Virology, December 1998, p. 10011-10019, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Li, Y., Guarino, L. A.
(2008). Roles of LEF-4 and PTP/BVP RNA Triphosphatases in Processing of Baculovirus Late mRNAs. J. Virol.
82: 5573-5583
[Abstract]
[Full Text]
-
Keppetipola, N., Jain, R., Shuman, S.
(2007). Novel Triphosphate Phosphohydrolase Activity of Clostridium thermocellum TTM, a Member of the Triphosphate Tunnel Metalloenzyme Superfamily. J. Biol. Chem.
282: 11941-11949
[Abstract]
[Full Text]
-
Gong, C., Smith, P., Shuman, S.
(2006). Structure-function analysis of Plasmodium RNA triphosphatase and description of a triphosphate tunnel metalloenzyme superfamily that includes Cet1-like RNA triphosphatases and CYTH proteins. RNA
12: 1468-1474
[Abstract]
[Full Text]
-
Knebel-Morsdorf, D., Quadt, I., Li, Y., Montier, L., Guarino, L. A.
(2006). Expression of Baculovirus Late and Very Late Genes Depends on LEF-4, a Component of the Viral RNA Polymerase Whose Guanyltransferase Function Is Essential.. J. Virol.
80: 4168-4173
[Abstract]
[Full Text]
-
Changela, A., Martins, A., Shuman, S., Mondragon, A.
(2005). Crystal Structure of Baculovirus RNA Triphosphatase Complexed with Phosphate. J. Biol. Chem.
280: 17848-17856
[Abstract]
[Full Text]
-
Kim, J., Parker, J. S. L., Murray, K. E., Nibert, M. L.
(2004). Nucleoside and RNA Triphosphatase Activities of Orthoreovirus Transcriptase Cofactor {micro}2. J. Biol. Chem.
279: 4394-4403
[Abstract]
[Full Text]
-
Gong, C., Martins, A., Shuman, S.
(2003). Structure-Function Analysis of Trypanosoma brucei RNA Triphosphatase and Evidence for a Two-metal Mechanism. J. Biol. Chem.
278: 50843-50852
[Abstract]
[Full Text]
-
Bisaillon, M., Bougie, I.
(2003). Investigating the Role of Metal Ions in the Catalytic Mechanism of the Yeast RNA Triphosphatase. J. Biol. Chem.
278: 33963-33971
[Abstract]
[Full Text]
-
Titterington, J. S., Nun, T. K., Passarelli, A. L.
(2003). Functional dissection of the baculovirus late expression factor-8 gene: sequence requirements for late gene promoter activation. J. Gen. Virol.
84: 1817-1826
[Abstract]
[Full Text]
-
Wu, X., Guarino, L. A.
(2003). Autographa californica Nucleopolyhedrovirus orf69 Encodes an RNA Cap (Nucleoside-2'-O)-Methyltransferase. J. Virol.
77: 3430-3440
[Abstract]
[Full Text]
-
Martins, A., Shuman, S.
(2003). Mapping the triphosphatase active site of baculovirus mRNA capping enzyme LEF4 and evidence for a two-metal mechanism. Nucleic Acids Res
31: 1455-1463
[Abstract]
[Full Text]
-
Acharya, A., Gopinathan, K. P.
(2002). Characterization of late gene expression factors lef-9 and lef-8 from Bombyx mori nucleopolyhedrovirus. J. Gen. Virol.
83: 2015-2023
[Abstract]
[Full Text]
-
Lin, G., Blissard, G. W.
(2002). Analysis of an Autographa californica Multicapsid Nucleopolyhedrovirus lef-6-Null Virus: LEF-6 Is Not Essential for Viral Replication but Appears To Accelerate Late Gene Transcription. J. Virol.
76: 5503-5514
[Abstract]
[Full Text]
-
Gong, C., Shuman, S.
(2002). Chlorella Virus RNA Triphosphatase. MUTATIONAL ANALYSIS AND MECHANISM OF INHIBITION BY TRIPOLYPHOSPHATE. J. Biol. Chem.
277: 15317-15324
[Abstract]
[Full Text]
-
Martins, A., Shuman, S.
(2001). Mutational Analysis of Baculovirus Capping Enzyme Lef4 Delineates an Autonomous Triphosphatase Domain and Structural Determinants of Divalent Cation Specificity. J. Biol. Chem.
276: 45522-45529
[Abstract]
[Full Text]
-
Ho, C. K., Shuman, S.
(2001). Trypanosoma brucei RNA Triphosphatase. ANTIPROTOZOAL DRUG TARGET AND GUIDE TO EUKARYOTIC PHYLOGENY. J. Biol. Chem.
276: 46182-46186
[Abstract]
[Full Text]
-
Lin, G., Slack, J. M., Blissard, G. W.
(2001). Expression and localization of LEF-11 in Autographa californica nucleopolyhedrovirus-infected Sf9 cells. J. Gen. Virol.
82: 2289-2294
[Abstract]
[Full Text]
-
Ho, C. K., Shuman, S.
(2001). A yeast-like mRNA capping apparatus in Plasmodiumfalciparum. Proc. Natl. Acad. Sci. USA
10.1073/pnas.061636198v1
[Abstract]
[Full Text]
-
Ho, C. K., Gong, C., Shuman, S.
(2001). RNA Triphosphatase Component of the mRNA Capping Apparatus of Paramecium bursaria Chlorella Virus 1. J. Virol.
75: 1744-1750
[Abstract]
[Full Text]
-
Pei, Y., Schwer, B., Hausmann, S., Shuman, S.
(2001). Characterization of Schizosaccharomyces pombe RNA triphosphatase. Nucleic Acids Res
29: 387-396
[Abstract]
[Full Text]
-
Jin, J., Guarino, L. A.
(2000). 3'-End Formation of Baculovirus Late RNAs. J. Virol.
74: 8930-8937
[Abstract]
[Full Text]
-
Ho, C. K., Martins, A., Shuman, S.
(2000). A Yeast-Based Genetic System for Functional Analysis of Viral mRNA Capping Enzymes. J. Virol.
74: 5486-5494
[Abstract]
[Full Text]
-
Pei, Y., Lehman, K., Tian, L., Shuman, S.
(2000). Characterization of Candida albicans RNA triphosphatase and mutational analysis of its active site. Nucleic Acids Res
28: 1885-1892
[Abstract]
[Full Text]
-
Luongo, C. L., Reinisch, K. M., Harrison, S. C., Nibert, M. L.
(2000). Identification of the Guanylyltransferase Region and Active Site in Reovirus mRNA Capping Protein lambda 2. J. Biol. Chem.
275: 2804-2810
[Abstract]
[Full Text]
-
Pei, Y., Ho, C. K., Schwer, B., Shuman, S.
(1999). Mutational Analyses of Yeast RNA Triphosphatases Highlight a Common Mechanism of Metal-dependent NTP Hydrolysis and a Means of Targeting Enzymes to Pre-mRNAs in Vivo by Fusion to the Guanylyltransferase Component of the Capping Apparatus. J. Biol. Chem.
274: 28865-28874
[Abstract]
[Full Text]
-
Lehman, K., Schwer, B., Ho, C. K., Rouzankina, I., Shuman, S.
(1999). A Conserved Domain of Yeast RNA Triphosphatase Flanking the Catalytic Core Regulates Self-association and Interaction with the Guanylyltransferase Component of the mRNA Capping Apparatus. J. Biol. Chem.
274: 22668-22678
[Abstract]
[Full Text]
-
Saha, N., Schwer, B., Shuman, S.
(1999). Characterization of Human, Schizosaccharomyces pombe, and Candida albicans mRNA Cap Methyltransferases and Complete Replacement of the Yeast Capping Apparatus by Mammalian Enzymes. J. Biol. Chem.
274: 16553-16562
[Abstract]
[Full Text]
-
Deshpande, T., Takagi, T., Hao, L., Buratowski, S., Charbonneau, H.
(1999). Human PIR1 of the Protein-tyrosine Phosphatase Superfamily Has RNA 5'-Triphosphatase and Diphosphatase Activities. J. Biol. Chem.
274: 16590-16594
[Abstract]
[Full Text]
-
Guarino, L. A., Jin, J., Dong, W.
(1998). Guanylyltransferase Activity of the LEF-4 Subunit of Baculovirus RNA Polymerase. J. Virol.
72: 10003-10010
[Abstract]
[Full Text]
-
Martins, A., Shuman, S.
(2000). Mechanism of Phosphoanhydride Cleavage by Baculovirus Phosphatase. J. Biol. Chem.
275: 35070-35076
[Abstract]
[Full Text]
-
Bisaillon, M., Shuman, S.
(2001). Structure-Function Analysis of the Active Site Tunnel of Yeast RNA Triphosphatase. J. Biol. Chem.
276: 17261-17266
[Abstract]
[Full Text]
-
Bisaillon, M., Shuman, S.
(2001). Functional Groups Required for the Stability of Yeast RNA Triphosphatase in Vitro and in Vivo. J. Biol. Chem.
276: 30514-30520
[Abstract]
[Full Text]
-
Hausmann, S., Vivares, C. P., Shuman, S.
(2002). Characterization of the mRNA Capping Apparatus of the Microsporidian Parasite Encephalitozoon cuniculi. J. Biol. Chem.
277: 96-103
[Abstract]
[Full Text]
-
Ho, C. K., Shuman, S.
(2001). A yeast-like mRNA capping apparatus in Plasmodiumfalciparum. Proc. Natl. Acad. Sci. USA
98: 3050-3055
[Abstract]
[Full Text]